The repeal of the “Tripartite Resolution” and the new outlook for pharmaceutical investment.
The 18th of March 2026 marks a turning point for intellectual property in our country. Through Joint Resolution 1/2026, published in the Official Gazette, the National Government has repealed the administrative restrictions which, over the last 14 years, have limited the patenting of chemical and pharmaceutical innovations.
